ArticleBMC musculoskeletal disorders2026
Integrin-β1/FAK signaling is involved in electrical stimulation to prevent disuse muscular atrophy induced by tail suspension in mice.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundElectrical stimulation is a widely used method for preventing and treating disuse muscle atrophy; however, the underlying mechanisms remain incompletely examined. Integrins, a class of transmembrane cell adhesion receptors, are considered primary mechanosensors involved in load-induced muscle growth. However, no previous studies have demonstrated whether integrin β1 and its downstream FAK signaling pathway are involved in the prevention of disuse muscle atrophy via electrical stimulation. Our study hypothesized that mechanical signals generated by electrical induced muscle contraction activate integrins, thereby contributing to muscle atrophy prevention. MATERIALS AND
methodsA disuse muscle atrophy model was constructed by tail suspending C57BL/6 mice for 2 weeks. The average physiological cross-sectional area, muscle strength, muscle fiber type, integrin β1, p-FAK, and p-p70S6K protein expression in the gastrocnemius and soleus muscles were measured following electrical stimulation.
resultsMice in the tail suspension with electrical stimulation (TS + E) group exhibited significantly greater physiological cross-sectional area and muscle strength compared with the tail suspension (TS) group (p < 0.05). Additionally, integrin β1 expression was lower in the TS group compared with the control group (p < 0.05). In contrast, in the TS + E group, expression levels of integrin β1, FAK, p-mTOR, and p-p70s6k were elevated compared with the TS group (p < 0.05). In GAS and SOL, the p-p70s6k/p70s6k ratio was significantly higher in the TS + E group compared with the TS group (p < 0.05). In GAS, the p-FAK/FAK ratio was higher in the TS + E group compared with the TS group (p < 0.01). However, no significant difference in p-FAK/FAK ratio was observed between the two groups in SOL.
conclusionElectrical stimulation upregulates the expression of the mechanosensor integrin β1 and enhances the phosphorylation of its downstream effector, FAK, in skeletal muscle. These effects may contribute to the attenuation of disuse muscle atrophy, providing preclinical evidence supporting the role of the integrin-β1/FAK signaling pathway in electrical stimulation-mediated muscle preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.